Precision Medicine News and Research

RSS

Current advances in nanoparticles and their role as anticancer drug-delivery vectors

Nanotechnology has contributed a great deal to the field of medical science. It has enabled researchers to design tools to deliver drugs to specific targets in a living organism.

4 Jun 2020

Computational models predict known biomarkers of inherited metabolic diseases

We are all unique. Our health is determined by our inherent genetic differences combined with our lifestyles and the environments in which we live.

4 Jun 2020

New technique opens the door to treating genetic forms of hearing loss

Using a new genetic engineering technique, known as base editing, researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard, have restored hearing in mice with a known recessive genetic mutation.

3 Jun 2020

Researchers design new microfluidic device to help detect blood clots

Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.

3 Jun 2020

Digital technology helps maintain clinical research operations during COVID-19 pandemic

As the COVID-19 pandemic has disrupted many routine medical services and discretionary surgical procedures, little attention has been paid to its impact on clinical research.

2 Jun 2020

New guidelines on storage of genomic information, improvements in EHR systems

Advances in genetic and genomic testing technology have not only introduced the utilization of clinical genomic information into virtually every area of medical care, this testing has become an essential tool to achieve the goal of precision medicine.

2 Jun 2020

ISSCR 2020 Virtual Meeting to deliver comprehensive scientific education program

The International Society for Stem Cell Research has transformed its annual scientific meeting into a virtual experience, bringing the global stem cell community together to share knowledge, collaborate, and network.

2 Jun 2020

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

By analyzing tumors from patients treated with immunotherapy for advanced kidney cancer in three clinical trials, Dana-Farber Cancer Institute scientists have identified several features of the tumors that influence their response to immune checkpoint inhibitor drugs.

30 May 2020

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

Chimeron Bio, an RNA therapeutics company, and George Mason University's National Center for Biodefense and Infectious Diseases, a leading institute conducting pioneering research on infectious diseases.

30 May 2020

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.

29 May 2020

A Senator from Arizona emerges as a pharma favorite

Sen. Kyrsten Sinema formed a congressional caucus to raise "awareness of the benefits of personalized medicine" in February. Soon after that, employees of pharmaceutical companies donated $35,000 to her campaign committee.

29 May 2020

Pitt researcher to explore the neurological sex-based divide in dementia

Fifty million people worldwide are living with dementia, a broad term for diseases and conditions characterized by progressive cognitive decline.

28 May 2020

Methods to move precision medicine from evaluation into practice and policy

Value in Health, the official journal of ISPOR - the professional society for health economics and outcomes research, announced today the publication of a series of articles focused on methods for moving from the evaluation of precision medicine into practice and policy.

26 May 2020

TissueGnostics achieves milestone in research community

TissueGnostics is pleased to announce achieving a new level of confidence within the international biomedical research community. As of May 2020, TissueGnostics has been referenced in over 1,500 individual research publications. High impact research made possible by TissueGnostics, emerging from 59 countries on 6 continents, results in a sum impact factor of 8,700.

From TissueGnostics 26 May 2020

Blood test could help doctors identify patients at risk of developing type 2 diabetes

Scientists have identified metabolites in the blood that accurately predict whether a woman will develop type 2 diabetes after experiencing a transient form of illness during pregnancy.

22 May 2020

Improving IVF Treatments by Imaging Sperm Cells

News-Medical spoke to Professor Natan Shaked about his new sperm cell imaging technique that could be used to help improve the outcomes of IVF treatments.

22 May 2020

USC-Olympus partnership in multiscale bioimaging furthers precision medicine

As a global leader in endoscopy and life science solutions, Olympus has long been committed to promoting awareness of cancer screening, prevention and testing. In this spirit, the company recently forged a partnership with the Lawrence J. Ellison Institute for Transformative Medicine at the University of Southern California (USC).

From Evident Corporation - Life Sciences 20 May 2020

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

For years, surgeons have operated on pancreatic cancer patients to remove what they thought was a localized tumor only to discover that the disease had spread to other, inoperable parts of the body. Now, a City of Hope molecular scientist thinks he may have found a way to prevent ineffective surgeries and prolong the lives of these patients.

18 May 2020

Roswell Park team proposes possible new strategy for treating pancreatic cancer

A possible new strategy for treating pancreatic cancer highlights the promise of collaboration between experts in both precision medicine and immunology.

18 May 2020

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) -- the most common and the most aggressive brain cancer -- has simply been age at diagnosis.

15 May 2020

Precision Medicine News and Research

Current advances in nanoparticles and their role as anticancer drug-delivery vectors

Computational models predict known biomarkers of inherited metabolic diseases

New technique opens the door to treating genetic forms of hearing loss

Researchers design new microfluidic device to help detect blood clots

Digital technology helps maintain clinical research operations during COVID-19 pandemic

New guidelines on storage of genomic information, improvements in EHR systems

ISSCR 2020 Virtual Meeting to deliver comprehensive scientific education program

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

Targeted therapy tepotinib shows durable response in NSCLC patients with METex14 skipping mutation

A Senator from Arizona emerges as a pharma favorite

Pitt researcher to explore the neurological sex-based divide in dementia

Methods to move precision medicine from evaluation into practice and policy

TissueGnostics achieves milestone in research community

Blood test could help doctors identify patients at risk of developing type 2 diabetes

Improving IVF Treatments by Imaging Sperm Cells

USC-Olympus partnership in multiscale bioimaging furthers precision medicine

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News